Cognitive Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder

Name: Cognitive Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder
SKU: 89104bbebdba1da6798349cb5049abe0
Price: 38.99 EUR
Availability: InStock

1/1

Afbeelding van Cognitive Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder

Bol

Prijzen vanaf

38,99

Uitgelicht

	38,99	Naar shop
VERGELIJK ALLE AANBIEDERS (1)

Beschrijving

Bol Avoidant/restrictive food intake disorder (ARFID) is a common eating disorder diagnosis that describes children and adults who cannot meet their nutritional needs, typically because of sensory sensitivity, fear of adverse consequences and/or apparent lack of interest in eating or food. This book is the first of its kind to offer a specialist treatment, specifically for ARFID. Developed, refined and studied in response to this urgent clinical need, this book outlines a specialiZed cognitive-behavioral treatment: Cognitive-Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder (CBT-AR). This treatment is designed for patients across all age groups, supported by real-life case examples and tools to allow clinicians to apply this new treatment in their own clinical settings.

Lees meer

Vergelijk aanbieders (1)

Sorteren op:

€ 38,99 Gratis verzending

Beschrijving (1)

Avoidant/restrictive food intake disorder (ARFID) is a common eating disorder diagnosis that describes children and adults who cannot meet their nutritional needs, typically because of sensory sensitivity, fear of adverse consequences and/or apparent lack of interest in eating or food. This book is the first of its kind to offer a specialist treatment, specifically for ARFID. Developed, refined and studied in response to this urgent clinical need, this book outlines a specialiZed cognitive-behavioral treatment: Cognitive-Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder (CBT-AR). This treatment is designed for patients across all age groups, supported by real-life case examples and tools to allow clinicians to apply this new treatment in their own clinical settings.

Lees meer